Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial

Semira Manaseki-Holland, Zabihullah Maroof, Jane Bruce, M Zulf Mughal, Mohammad Isaq Masher, Zulfiqar A Bhutta, Gijs Walraven, Daniel Chandramohan, Semira Manaseki-Holland, Zabihullah Maroof, Jane Bruce, M Zulf Mughal, Mohammad Isaq Masher, Zulfiqar A Bhutta, Gijs Walraven, Daniel Chandramohan

Abstract

Background: Vitamin D has a role in regulating immune function, and its deficiency is a suggested risk factor for childhood pneumonia. Our aim was to assess whether oral supplementation of vitamin D(3) (cholecalciferol) will reduce the incidence and severity of pneumonia in a high-risk infant population.

Methods: We did a randomised placebo-controlled trial to compare oral 100,000 IU (2·5 mg) vitamin D(3) with placebo given to children aged 1-11 months in Kabul, Afghanistan. Randomisation was by use of a computer-generated list. Vitamin D or placebo was given by fieldworkers once every 3 months for 18 months. Children presenting at the study hospital with signs of pneumonia had their diagnosis confirmed radiographically. Our primary outcome was the first or only episode of radiologically confirmed pneumonia. Our analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00548379.

Findings: 1524 children were assigned to receive vitamin D(3) and 1522 placebo. There was no significant difference between the incidence of first or only pneumonia between the vitamin D (0·145 per child per year, 95% CI 0·129-0·164) and the placebo group (0.137, 0·121-0·155); the incidence rate ratio was 1·06 (95% CI 0·89-1·27). From 652 children during five separate periods of testing serum calcifediol, only one child in each of two testing periods had results greater than 375 nmol/L in the intervention group--a toxic level.

Interpretations: Quarterly bolus doses of oral vitamin D(3) supplementation to infants are not an effective intervention to reduce the incidence of pneumonia in infants in this setting.

Funding: Wellcome Trust and British Council.

Copyright © 2012 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1
Trial profile *One case was a severely malnourished child and another had received high-dose vitamin D within the past 3 months. †Did not want to be enrolled in the project for reasons such as did not want to go to Maiwand hospital, did not want the fieldworkers to come to their house, and other with no clear reasons. ‡The syringe with code number of 2706 was given to the child with study number of 2707, with 1070 to 1084, and with 2393 to 2939. §The syringe with code number of 1418 was given to the child with study number of 1814 and with 2335 to 2235. ¶The syringe with code number of 2215 was given to the child with study number of 2224.
Figure 2
Figure 2
Proportion of children with a first episode of pneumonia over time
Figure 3
Figure 3
Boxplot of serum calcifediol concentration Vertical lines represent the time of supplementation, and each placebo and vitamin D pair represent a sampling time. Boxes are medians with IQRs. Circles represent outliers. For November and December, 2008, p1·0. One child in the vitamin D group in January, 2008, and one in May, 2008, had serum concentrations greater than 375 nmol/L (not shown).

References

    1. Muhe L, Lulseged S, Mason KE, Simoes EA. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet. 1997;349:1801–1804.
    1. Wayse V, Yousafzai A, Mogale K, Filteau S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur J Clin Nutr. 2004;58:563–567.
    1. Manaseki-Holland S, Qader G, Isaq Masher M. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health. 2010;15:1148–1155.
    1. White HJ. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008;76:3837–3843.
    1. Liu PT, Stenger S, Li H. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773.
    1. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122:398–417.
    1. Pettifor JM. Vitamin D &/or calcium deficiency rickets in infants & children: a global perspective. Indian J Med Res. 2008;127:245–249.
    1. Fraser DR. Vitamin D-deficiency in Asia. J Steroid Biochem Mol Biol. 2004;89–90:491–495.
    1. Ward LM, Gaboury I, Ladhani M, Zlotkin S. Vitamin D-deficiency rickets among children in Canada. CMAJ. 2007;177:161–166.
    1. Tchibindat F, Ghafoori A, Maroof Z, Hedayatullah S, Qulam R. Care practices formative research: Ghozarah district community, Herat, Afghanistan. UNICEF and MOH Afghanistan; Herat: 2003.
    1. Dawodu A, Agarwal M, Hossain M, Kochiyil J, Zayed R. Hypovitaminosis D and vitamin D deficiency in exclusively breast-feeding infants and their mothers in summer: a justification for vitamin D supplementation of breast-feeding infants. J Pediatr. 2003;142:169–173.
    1. Manaseki-Holland S, Zulf Mughal M, Bhutta Z, Qasem Shams M. Vitamin D status of socio-economically deprived children in Kabul, Afghanistan. Int J Vitam Nutr Res. 2008;78:16–20.
    1. Vervel C, Zeghoud F, Boutignon H, Tjani JC, Walrant-Debray O, Garabédian M. Fortified milk and supplements of oral vitamin D. Comparison of the effect of two doses of vitamin D (500 and 1000 UI/d) during the first trimester of life. Arch Pediatr. 1997;4:126–132. (in French).
    1. Gallo S, Jean-Philippe S, Rodd C, Weiler HA. Vitamin D supplementation of Canadian infants: practices of Montreal mothers. Appl Physiol Nutr Metab. 2010;35:303–309.
    1. UNICEF . Multiple indicator cluster survey 2003, Afganistan. Central Statistics Office Afghanistan Transitional Authority and UNICEF; Kabul: 2004.
    1. Zeghoud F, Ben-Mekhbi H, Djeghri N, Garabédian M. Vitamin D prophylaxis during infancy: comparison of the long-term effects of three intermittent doses (15, 5, or 2·5 mg) on 25-hydroxyvitamin D concentrations. Am J Clin Nutr. 1994;60:393–396.
    1. WHO Pneumonia Vaccine Trial Investigators' Group . Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children (WHO/V&B/01.35) WHO Department of Vaccine and Biologicals; Geneva: 2001.
    1. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004;82:895–903.
    1. Enwere G, Cheung YB, Zaman SM. Epidemiology and clinical features of pneumonia according to radiographic findings in Gambian children. Trop Med Int Health. 2007;12:1377–1385.
    1. Martineau AR, Timms PM, Bothamley GH. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2010;377:242–250.
    1. Bischoff-Ferrari HA, Willett WC, Wong JB. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169:551–561.
    1. Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res. 2009;29:3675–3684.
    1. Sanders KM, Stuart AL, Williamson EJ. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303:1815–1822.
    1. Avenell A, Cook JA, Maclennan GS, Macpherson GC. Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438) Age Ageing. 2007;36:574–577.
    1. Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract. 2009;15:438–449.
    1. Aloia JF, Talwar SA, Pollack S, Yeh J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med. 2005;165:1618–1623.
    1. Li-Ng M, Aloia JF, Pollack S. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect. 2009;137:1396–1404.
    1. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91:1255–1260.
    1. Morcos MM, Gabr AA, Samuel S. Vitamin D administration to tuberculous children and its value. Boll Chim Farm. 1998;137:157–164.
    1. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. 2006;38:3–5.
    1. Martineau AR, Wilkinson RJ, Wilkinson KA. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med. 2007;176:208–213.
    1. Wejse C, Gomes VF, Rabna P. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2009;179:843–850.
    1. Smith H, Anderson FH, Raphael H, Maslin P, Crozier S, Cooper C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 2007;46:1852–1857.
    1. Rehman PK. Sub-clinical rickets and recurrent infection. J Trop Pediatr. 1994;40:58.
    1. Kutluk G, Çetinkaya F, Banak M. Comparisons of oral calcium, high dose vitamin D and a combination of these in the treatment of nutritional rickets in children. J Trop Pediatr. 2002;48:351–353.
    1. Zeghoud F, Vervel C, Guillozo H, Walrant-Debray O, Boutignon H, Garabédian M. Subclinical vitamin D deficiency in neonates: definition and response to vitamin D supplements. Am J Clin Nutr. 1997;65:771–778.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner